Stephen H. Willard

Insider Reports History

Location
Wilmington, DE
Signature
/s/ Paul T. Lehr, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen H. Willard:

Form 4 holding CHIEF EXECUTIVE OFFICER, Director

NRX Pharmaceuticals, Inc.

Security class
Common Stock, par value $0.001 per share
Shares / value
50,000
Estimated value
$15,995
Report date
16 Dec 2022
Price
$0.3199
Ownership
Direct
Form 4 holding Chief Executive Officer

Longeveron Inc.

Security class
Stock Option (right to buy)
Shares / value
200,000
Estimated value
Report date
02 Mar 2026
Price
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount

Insider Reports Filed by Stephen H. Willard

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .